KOLIGO THERAPEUTICS
Koligo Therapeutics’ mission is to develop, manufacture, and commercialize transformative cell therapies for the treatment of pancreatic diseases.Koligo is dedicated to supporting their mission while respecting their values.Their employees agree in writing to certain professional standards to codify our mutual understanding of Koligo’s ethics and conduct .
KOLIGO THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Louisville, Kentucky, United States
Country:
United States
Website Url:
http://www.kyslecel.com
Total Employee:
1+
Status:
Active
Contact:
40202 1-502-242-5890
Email Addresses:
[email protected]
Total Funding:
3.65 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 AWS Global Accelerator WPForms
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Bergen Asset Management
Bergen Asset Management investment in Post-IPO Debt - Koligo therapeutics
Official Site Inspections
http://www.kyslecel.com Semrush global rank: 6.73 M Semrush visits lastest month: 840
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 